Применение андрогенного прайминга при сниженном овариальном резерве у женщин с бесплодием в программах вспомогательных репродуктивных технологий (ЭКО/ИКСИ)
- Авторы: Гависова А.А.1, Камалетдинов Н.С.1, Назаренко Т.А.1, Долгушина Н.В.1
-
Учреждения:
- ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
- Выпуск: № 9 (2022)
- Страницы: 94-101
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/249535
- DOI: https://doi.org/10.18565/aig.2022.9.94-101
- ID: 249535
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Полный текст
Об авторах
Алла Анатольевна Гависова
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: gavialla@yandex.ru
к.м.н., с.н.с. l-го гинекологического отделения
Наиль Садекович Камалетдинов
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: sunsh86@mail.ru
эмбриолог 1-го гинекологического отделения
Татьяна Алексеевна Назаренко
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: t_nazarenko@oparina4.ru
д.м.н., профессор, директор института репродуктивной медицины
Наталия Витальевна Долгушина
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: n_dolgushina@oparina4.ru
д.м.н., профессор, заместитель директора - руководитель департамента организации научной деятельности
Список литературы
- Jeve Y., Bhandari H. Effective treatment protocol for poor ovarian response: a systematic review and meta-analysis. J. Hum. Reprod. Sci. 2016; 9(2):70-81. 9(2):70-81. https://dx.doi.org/10.4103/0974-1208.183515.
- Ferraretti A.P., La Marca A., Fauser B.C.J.M., Tarlatzis B., Nargund G., Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod. 2011; 26(7): 1616-24. https://dx.doi.org/10.1093/humrep/der092.
- MacLaughlin D.T., Donahoe P.K. Sex determination and differentiation. N. Engl. J. Med. 2004; 350(4): 367-78. https://dx.doi.org/10.1056/NEJMra022784.
- Neves A.R., Montoya-Botero P., Polyzos N.P. The role of androgen supplementation in women with diminished ovarian reserve: time to randomize, not meta-analyze. Front. Endocrinol. (Lausanne). 2021; 12: 653857. https://dx.doi.org/10.3389/fendo.2021.653857.
- Richardson A., Jayaprakasan K. The use of androgen priming in women with reduced ovarian reserve undergoing assisted reproductive technology. Semin. Reprod. Med. 2021; 39(5-06): 207-19. https://dx.doi.org/10.1055/s-0041-1735646.
- Astapova O., Minor B.M.N., Hammes S.R. Physiological and pathological androgen actions in the ovary. Endocrinology. 2019; 160(5): 1166-74. https://dx.doi.org/10.1210/en.2019-00101.
- Ryan K.J., Petro Z., Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and tehcal cells. J. Clin. Endocrinol. Metab. 1968; 28(3): 355-8. https://dx.doi.org/10.1210/jcem-28-3-355.
- Horie K., Takakura K., Fujiwara H. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum. Reprod. 1992; 7(2): 184-90. https://dx.doi.org/10.1093/oxfordjournals.humrep.a137614.
- Suzuki T., Sasano H., Kimura N., Tamura M., Fukaya T., Yajima A., Nagura H. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum. Reprod. 1994; 9(9): 1589-95. https://dx.doi.org/10.1093/oxfordjournals.humrep.a138757.
- Hillier S.G., Tetsuka M., Fraser H.M. Location and developmental regulation of androgen receptor in primate ovary. Hum. Reprod. 1997; 12(1): 107-11. https://dx.doi.org/10.1093/humrep/12.1.107.
- Weil S.J., Vendola K., Zhou J., Adesanya O.O., Wang J., Okafor J., Bondy C.A. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J. Clin. Endocrinol. Metab. 1998; 83(7): 2479-85. https://dx.doi.org/10.1210/jcem.83.7.4917.
- Harlow C.R., Shaw H.J., Hillier S.G., Hodges J.K. Factors influencing follicle-stimulating hormone-responsive steroidogenesis in marmoset granulosa cells: effects of androgens and the stage of follicular maturity. Endocrinology. 1988; 122(6): 2780-7. https://dx.doi.org/10.1210/endo-122-6-2780.
- Shaw H.J., Hillier S.G., Hodges J.K. Developmental changes in luteinizing hormone/human chorionic gonadotropin steroidogenic responsiveness in marmoset granulosa cells: effects of follicle-stimulating hormone and androgens. Endocrinology. 1989; 124(4): 1669-77. https://dx.doi.org/10.1210/endo-124-4-1669.
- Hillier S.G., Ross G.T. Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol. Reprod. 1979; 20(2): 261-8.
- Billig H., Furuta I., Hsueh J.W. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 1993; 133(5): 2204-12. https://dx.doi.org/10.1210/endo.133.5.8404672.
- Vendola K.A., Zhou J., Adesanya O.O., Weil S.J., Bondy C.A. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest. 1998; 101(12): 2622-9. https://dx.doi.org/10.1172/JCI2081.
- Spinder T., Spijkstra J., Van Den Tweel J. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J. Clin. Endocrinol. Metab. 1989; 69(1): 151-7. https://dx.doi.org/10.1210/jcem-69-1-151.
- Jonard S., Robert Y., Cortet-Rudelli C., Pigny P., Decanter C., Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum. Reprod. 2003; 18(3): 598-603. https://dx.doi.org/10.1093/humrep/deg115.
- Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 2003; 88(12): 5957-62. https://dx.doi.org/10.1210/jc.2003-030727.
- Gervasio C.G., Bernuci M.P., Silva-de-Sa M.F., de Rosa-e-Silva A.C.J.S. The role of androgen hormones in early follicular development. ISRN Obstet. Gynecol. 2014; 2014 : 818010. https://dx.doi.org/10.1155/2014/818010.
- Casson PR., Lindsay M.S., Pisarska M.D., Carson S.A., Buster J.E. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum. Reprod. 2000; 15(10): 2129-32. https://dx.doi.org/10.1093/humrep/15.10.2129.
- Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum. Reprod. 2011; 26(6):1270-83. https://dx.doi.org/10.1093/humrep/der037.
- Slater C.C., Souter I., Zhang C., Guan C., Stanczyk F.Z., Mishell D.R. Pharmacokinetics of testosterone after percutaneous gel or buccal administration. Fertil. Steril. 2001; 76(1): 32-7. https://dx.doi.org/10.1016/s0015-0282(01)01827-1.
- Davison S.L., Bell R., Donath S., Montalto J.G., Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 2005; 90(7): 3847-53. https://dx.doi.org/10.1210/jc.2005-0212.
- Nagels H.E., Rishworth J.R., Siristatidis C.S., Kroon B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst. Rev. 2015; 11: CD009749.
- Neves A.R., Montoya-Botero P., Polyzos N.P. Androgens and diminished ovarian reserve:the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis. Am. J. Obstet. Gynecol. 2022; 227(3): 401-413.e18. https://dx.doi.org/10.1016/j.ajog.2022.03.051.
- Yeung T.W.Y., Li R.H.W., Lee V.C.Y., Ho P.C., Ng E.H.Y. A randomized doubleblinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. J.,. Clin. Endocrinol. Metab. 2013; 98(1): 380-8. https://dx.doi.org/10.1210/jc.2012-3071.
- Singh A.B., Lee M.L., Sinha-Hikim I., Kushnir M., Meikle W., Rockwood A. et al. Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 2006; 91(1): 136-44. https://dx.doi.org/10.1210/jc.2005-1640.
- Fabregues F., Penarrubia J., Creus M., Manau D., Casals G., Carmona F., Balasch J. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum. Reprod. 2009; 24(2): 349-59. https://dx.doi.org/10.1093/humrep/den428.
- Kim C.H., Howles C.M., Lee H.A. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil. Steril. 2011; 95(2): 679-83. https://dx.doi.org/10.1016/j.fertnstert.2010.07.1077.
- Kim C.H., Ahn J.W., Moon J.W., Kim S.H., Chae H.D., Kang B.M. Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders. Dev. Reprod. 2014; 18(3): 145-52. https://dx.doi.org/10.12717/DR.2014.18.3.145.
- Amirikia H., Savoy-Moore R.T., Sundareson A.S., Moghissi K. The effects of long-term androgen treatment on the ovary. Fertil. Steril. 1986; 45(2): 202-8. https://dx.doi.org/10.1016/s0015-0282(16)49155-7.
- Burger H.G. Androgen production in women. Fertil. Steril. 2002; 77(Suppl. 4): S3-5. 1 https://dx.doi.org/10.1016/s0015-0282(02)02985-0.